EAA receptor antagonists (NPS Allelix)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameEAA receptor antagonists (NPS Allelix)
Drug Alias NameEAA receptor antagonists (NPS Allelix/Lilly)excitatory amino acids (NPS Allelix/Eli Lilly)neurologicals (NPS Allelix/Lilly)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor agonistsSerotonin (5-HT) receptor agonistsMonoamine oxidase B inhibitors
TargetsMetabotropic glutamate receptorMonoamine oxidase BSerotonin (5-HT) receptor
Therapy Area/IndicationsSchizophreniaCognition DisordersPain +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNps Allelix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNps Allelix CorpEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsSchizophreniaCognition DisordersPain +[7] 

Other Information

ATC CodeN/A
Related LinksN/A